Imaging displays, from consumer to medical grade, have come a long way since the days of bulky screens and low resolutions. Today, flat panel displays in the healthcare arena have increasing capacity to offer improved contrast ratios, truer colors, better energy efficiency, high luminance and more. A variety of vendors continue to improve the technology to better display imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, positron emission tomography (PET), mammography and ultrasound, and to ensure screens remain DICOM (digital imaging and communications in medicine) compliant.



Tomotherapy and volumetric modulated arc therapy (VMAT) have emerged as two popular types of intensity modulated radiation therapy (IMRT) for the treatment of complex tumors. Because physicians can modulate or control the intensity of the radiation beam in VMAT and tomotherapy, both treatments provide high precision radiation with which tumors that are curved around critical organs can be treated.



Cardiac ultrasound technology has advanced to keep up with several trends. These include improved workflow for greater efficiency, expanded use of qualification metrics, expanded use of 3-D echo to speed exam times and improve operator reproducibility, and expanded use of 3-D transesophageal echo (TEE) to aid guidance in the growing area of transcatheter structural heart procedures. Here are a few examples of how the newest technology is addressing these trends.


With the addition of its third 3D mammography system in early 2014, the University of Colorado Hospital established 3D as the standard of care in its breast imaging department. Located in Aurora, Colo., the hospital currently provides mammograms in two centers in the Denver area, and on its “Pink Lifesaver” mammography coach, which covers surrounding communities. The transition to 3D got a jump-start from fundraising efforts by the hospital’s “Men for the Cure” foundation, with donations from the group used to purchase the first 3D system and the mobile coach.  

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular imaging technologies, clinical applications, and translational and advanced research topics for molecular imaging professionals — nuclear medicine physicians, scientists, radiologists, cardiologists, pharmacists, technologists, researchers, and others involved and interested in nuclear medicine and molecular imaging and therapy.


Fujifilm Medical Systems U.S.A. Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) of the Aspire Cristalle.

 

Siemens Healthcare recently submitted its premarket approval application (PMA) for the Mammomat Inspiration with Breast Tomosynthesis option to the U.S. Food and Drug Administration (FDA)

Subscribe Now